Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.78 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.78 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.41 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.41 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzyl Bromide SCHEMBL5964841 | 0.88 | — | — | |
| SCHEMBL20389321 | 0.88 | TSHR (1.00) | TSHRALDH1A1TRPA1TAAR1TDP1 | |
| Benzyl Bromide SCHEMBL1066 | 0.88 | — | — | |
| Benzyl Bromide SCHEMBL9000955 | 0.88 | TSHR (1.00) | TSHRALDH1A1TRPA1TAAR1TDP1 | |
| Benzyl Bromide SCHEMBL1331189 | 0.88 | — | — | |
| Benzyl Bromide SCHEMBL5757393 | 0.88 | TSHR (1.00) | TSHRALDH1A1TRPA1TAAR1TDP1 | |
| Benzyl Bromide SCHEMBL28230984 | 0.86 | ALDH1A1 (0.82) | TSHRALDH1A1TRPA1TAAR1TDP1 | |
| Benzyl Bromide SCHEMBL3764294 | 0.86 | ALDH1A1 (0.82) | TSHRALDH1A1TRPA1TAAR1TDP1 | |
| Benzyl Bromide SCHEMBL28763610 | 0.86 | ALDH1A1 (0.82) | TSHRALDH1A1TRPA1TDP1CES2 | |
| Benzyl Bromide SCHEMBL27727270 | 0.86 | ALDH1A1 (0.82) | TSHRALDH1A1TRPA1TAAR1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11717481-B2 | Reduction of flake-like aggregation in nanoparticulate active agent compositions | ALKERMES PHARMA IRELAND LIMITED (IE) | 2023-08-08 | — | — | US | claimed |
| CN-113260637-B | Modified diene (co) polymers, method for the production thereof and use thereof as flame retardants | 公共型股份公司希布尔控股 | 2023-06-16 | — | — | CN | claimed |
| US-20220211626-A1 | REDUCTION OF FLAKE-LIKE AGGREGATION IN NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT | 2022-07-07 | — | — | US | claimed |
| US-11253478-B2 | Reduction of flake-like aggregation in nanoparticulate active agent compositions | ALKERMES PHARMA IRELAND LIMITED (IE) | 2022-02-22 | — | — | US | claimed |
| EP-3755148-A1 | NANOSUSPENSIONS OF SALSALATE AND METHODS OF USING THE SAME | RHNanoPharma (US) | 2020-12-30 | — | — | EP | claimed |
| US-20200390737-A1 | NANOSUSPENSIONS OF SALSALATE AND METHODS OF USING THE SAME | RHNANOPHARMA (US) | 2020-12-17 | — | — | US | claimed |
| WO-2020065541-A1 | MICROEMULSIONS AND METHODS OF USE | MOROCCANOIL ISRAEL, LTD. (IL) | 2020-04-02 | — | — | WO | claimed |
| WO-2019165240-A1 | NANOSUSPENSIONS OF SALSALATE AND METHODS OF USING THE SAME | RHNANOPHARMA (US) | 2019-08-29 | — | — | WO | claimed |
| CN-110036045-A | The production method of polyacrylonitrile | SABIC环球技术有限责任公司 | 2019-07-19 | — | — | CN | claimed |
| US-20180250229-A1 | REDUCTION OF FLAKE-LIKE AGGREGATION IN NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | ALKERMES PHARMA IRELAND LIMITED (IE) | 2018-09-06 | — | — | US | claimed |
| WO-2003066021-A2 | DRUG NANOPARTICLES WITH LYSOZYME SURFACE STABILISER | ELAN PHARMA INTERNATIONAL, LTD. (IE) | 2003-08-14 | — | — | WO | claimed |
| US-20030137067-A1 | Compositions having a combination of immediate release and controlled release characteristics | ELAN PHARMA INTERNATIONAL LTD. | 2003-07-24 | — | — | US | claimed |
| US-20030095928-A1 | Nanoparticulate insulin | ELAN PHARMA INTERNATIONAL LIMITED | 2003-05-22 | — | — | US | claimed |
| WO-2003030872-A2 | COMPOSITIONS HAVING A COMBINATION OF PARTICLES FOR IMMEDIATE RELEASE AND FOR CONTROLLED RELEASE | ELAN PHARMA INTERNATIONAL LTD. (IE) | 2003-04-17 | — | — | WO | claimed |
| WO-2003024425-A1 | NANOPARTICULATE INSULIN FORMULATIONS | ELAN PHARMA INTERNATIONAL, LTD. (IE) | 2003-03-27 | — | — | WO | claimed |
| EP-0553111-B1 | THIN FILM COMPOSITE ULTRAFILTRATION MEMBRANE | ALLIED SIGNAL INC (US) | 1995-09-06 | — | — | EP | claimed |
| EP-0553111-A1 | THIN FILM COMPOSITE ULTRAFILTRATION MEMBRANE. | ALLIED SIGNAL INC (US) | 1993-08-04 | — | — | EP | claimed |
| US-5145584-A | Polymer anions and cations for membrane | ALLIED-SIGNAL INC. (US) | 1992-09-08 | — | — | US | claimed |
| WO-1992010280-A1 | THIN FILM COMPOSITE ULTRAFILTRATION MEMBRANE | ALLIED-SIGNAL INC. (US) | 1992-06-25 | — | — | WO | claimed |
| US-5085775-A | Casting solution of polyelectrolyte complex on microporous support; asymmetric; separation of low molecular weight solutes | ALLIED-SIGNAL INC. (US) | 1992-02-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200390737-A1 | NANOSUSPENSIONS OF SALSALATE AND METHODS OF USING THE SAME | TUBAL3, TUBB6, TUBA1A | TSHR 4295/4885ALDH1A1 316/4885TRPA1 4508/4885 |
| US-20030137067-A1 | Compositions having a combination of immediate release and controlled release characteristics | NAPA, CD63, RPL36 | TSHR 2057/4885ALDH1A1 2257/4885TRPA1 3761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.